| Medicinal plants used by traditional medicine practitioners for the treatment of HIV/AIDS and related conditions in Uganda M Lamorde, JRS Tabuti, C Obua, C Kukunda-Byobona, H Lanyero, ... Journal of ethnopharmacology 130 (1), 43-53, 2010 | 217 | 2010 |
| Adoption of COVID-19 triage strategies for low-income settings RR Ayebare, R Flick, S Okware, B Bodo, M Lamorde The Lancet. Respiratory medicine 8 (4), e22, 2020 | 132 | 2020 |
| Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial K Kintu, TR Malaba, J Nakibuka, C Papamichael, A Colbers, K Byrne, ... The Lancet HIV 7 (5), e332-e339, 2020 | 101 | 2020 |
| Unintended pregnancies observed with combined use of the levonorgestrel contraceptive implant and efavirenz-based antiretroviral therapy: a three-arm pharmacokinetic evaluation … KK Scarsi, KM Darin, S Nakalema, DJ Back, P Byakika-Kibwika, LJ Else, ... Clinical Infectious Diseases 62 (6), 675-682, 2016 | 96 | 2016 |
| Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults P Byakika-Kibwika, M Lamorde, J Mayito, L Nabukeera, R Namakula, ... Journal of antimicrobial chemotherapy 67 (9), 2213-2221, 2012 | 96 | 2012 |
| Antenatal syphilis screening using point-of-care testing in Sub-Saharan African countries: a cost-effectiveness analysis A Kuznik, M Lamorde, A Nyabigambo, YC Manabe PLoS medicine 10 (11), e1001545, 2013 | 94 | 2013 |
| Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2 … V Avataneo, A de Nicolò, J Cusato, M Antonucci, A Manca, A Palermiti, ... Journal of Antimicrobial Chemotherapy 75 (7), 1772-1777, 2020 | 89 | 2020 |
| Uganda’s experience in Ebola virus disease outbreak preparedness, 2018–2019 JR Aceng, AR Ario, AN Muruta, I Makumbi, M Nanyunja, I Komakech, ... Globalization and Health 16, 1-12, 2020 | 87 | 2020 |
| Pharmacology of second-line antituberculosis drugs and potential for interactions with antiretroviral agents KM Coyne, AL Pozniak, M Lamorde, M Boffito Aids 23 (4), 437-446, 2009 | 85 | 2009 |
| Traditional herbal medicine use associated with liver fibrosis in rural Rakai, Uganda BJ Auerbach, SJ Reynolds, M Lamorde, C Merry, C Kukunda-Byobona, ... PLoS One 7 (11), e41737, 2012 | 80 | 2012 |
| Estimating the public health burden associated with adverse pregnancy outcomes resulting from syphilis infection across 43 countries in sub-Saharan Africa A Kuznik, AG Habib, YC Manabe, M Lamorde Sexually transmitted diseases 42 (7), 369-375, 2015 | 79 | 2015 |
| Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: a randomised trial (DolPHIN-1 study) C Waitt, C Orrell, S Walimbwa, Y Singh, K Kintu, B Simmons, ... PLoS medicine 16 (9), e1002895, 2019 | 78 | 2019 |
| Dolutegravir-associated hyperglycaemia in patients with HIV M Lamorde, M Atwiine, NC Owarwo, A Ddungu, EO Laker, F Mubiru, ... The Lancet HIV 7 (7), e461-e462, 2020 | 70 | 2020 |
| Optimizing antimicrobial use: challenges, advances and opportunities TM Rawson, RC Wilson, D O’Hare, P Herrero, A Kambugu, M Lamorde, ... Nature Reviews Microbiology 19 (12), 747-758, 2021 | 68 | 2021 |
| Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis A Kuznik, AG Habib, D Munube, M Lamorde BMC health services research 16, 1-12, 2016 | 68 | 2016 |
| Cost effectiveness of a pharmacy-only refill program in a large urban HIV/AIDS clinic in Uganda JB Babigumira, B Castelnuovo, A Stergachis, A Kiragga, P Shaefer, ... Plos one 6 (3), e18193, 2011 | 64 | 2011 |
| Potential impact of task-shifting on costs of antiretroviral therapy and physician supply in Uganda JB Babigumira, B Castelnuovo, M Lamorde, A Kambugu, A Stergachis, ... BMC health services research 9, 1-6, 2009 | 58 | 2009 |
| Drug–drug interactions, effectiveness, and safety of hormonal contraceptives in women living with HIV KK Scarsi, KM Darin, CA Chappell, SM Nitz, M Lamorde Drug safety 39 (11), 1053-1072, 2016 | 56 | 2016 |
| Cost-effectiveness of antivenoms for snakebite envenoming in 16 countries in West Africa M Hamza, MA Idris, MB Maiyaki, M Lamorde, JP Chippaux, DA Warrell, ... PLoS neglected tropical diseases 10 (3), e0004568, 2016 | 56 | 2016 |
| Artemether‐lumefantrine co‐administration with antiretrovirals: population pharmacokinetics and dosing implications RM Hoglund, P Byakika‐Kibwika, M Lamorde, C Merry, M Ashton, ... British journal of clinical pharmacology 79 (4), 636-649, 2015 | 55 | 2015 |
